ANEUVO helps Georgetown teen with cerebral palsy defy odds

Fox 7 News: Teen with cerebral palsy defying odds
For most people with cerebral palsy, it's a disease that, year after year, robs them of their independence. But 14-year-old Martin has defied those expectations, thanks partly to new spinal stimulation technology at the University of St. Augustine. Martin was the first to be enrolled in a pilot study this year using ExaStim.

SCI Care: What Really Matters

ISCoS Episode on SCI Care: What Really Matters
Transformative Therapies for Chronic Spinal Cord Injury: The Role of Transcutaneous Spinal Stimulation in SCI Care.
In this episode of ‘SCI Care: What Really Matters’ we focus on sharing information on the technological innovations in our field with a discussion about transcutaneous spinal stimulation (TSS).


ANEUVO Launches US Study of ExaStim, a Non-invasive Spinal Neuromodulation System to Evaluate its Safety and Effectiveness for Paralysis due to Spinal Cord Injury

The ASPIRE clinical study is designed to demonstrate the safety and efficacy of the ExaStim® TSS system using non-invasive spinal cord stimulation to improve/regain the motor function of individuals with SCI. A maximum of 140 patients will be enrolled at up to 14 sites in the U.S.

ANEUVO CEO Yi-Kai Lo Presents at Unite 2 Fight for Paralysis

ANEUVO CEO Yi-Kai Lo to Present at Unite 2 Fight for Paralysis

The symposium is “a collaborative gathering that prioritizes the voice of the Spinal Cord Injury (SCI) Community, bringing together research scientists, clinicians, and community advocates, along with investors and industry leaders to exchange information and strategies for achieving recovery from SCI.” The event takes place Thursday, October 21, through Saturday, October 23, 2021.

Go to Top